PharmaRadar360

Entity and regulatory intelligence

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 694 of 767

Advanced search

🌍Mar 16Industryir.biolinerx.comTier 1 · Company source

BioLineRx to Report 2025 Annual Results on March 23, 2026

BioLineRxOriginal source

🌍Mar 16Industryzentiva.comTier 1 · Company source

Zentiva publishes 2025 Sustainability Report reinforcing commitment to people, partners and the planet.

Zentiva (Global)Original source

🌍Mar 14Mediaechonous.comTier 2 · Direct publisher

Evaluating Point-of-Care Ultrasound Systems & Clinical Use Case

EchoNousOriginal source

🌍Mar 14Researchopenclinica.comTier 2 · Direct publisher

Why Fragmented Workflows Are the Real Clinical Trial Enrollment Problem

OpenClinicaOriginal source

🇺🇸Mar 14Industryvikingtherapeutics.comTier 1 · Company source

Impact of Subcutaneous VK2735 on Weight, Prediabetes, and Cardiometabolic Status: The VENTURE Study - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Mar 14Industryvikingtherapeutics.comTier 1 · Company source

Results From the 13-Week VENTURE Phase 2a Study of the GLP-1/GIP Co-Agonist VK2735 in Obese Patients - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Mar 14Industryvikingtherapeutics.comTier 1 · Company source

First-in-Human Study of an Oral Formulation of the GLP-1/GIP Co-Agonist VK2735 in Healthy Adults - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Mar 14Industryvikingtherapeutics.comTier 1 · Company source

Obesity Impact on Incidence of Chronic Comorbid Conditions - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Mar 14Industryvikingtherapeutics.comTier 1 · Company source

Prevalence of cardiometabolic conditions across body mass index categories—the distinct burden of severe (class III) obesity - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Mar 14Industryvikingtherapeutics.comTier 1 · Company source

VANQUISH-2: Phase 3, Randomized, Double-blind, Placebo-controlled, Trial of weekly subcutaneous administration of VK2735 in Obese or Overweight Adults with Type 2 Diabetes - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Mar 14Industryvikingtherapeutics.comTier 1 · Company source

Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇫🇷Mar 13Industrycellectis.comTier 1 · Company source

Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

CellectisOriginal source

🌍Mar 13Industrycibeles.com.uyTier 1 · Company source

Facily 144sc

Cibeles (Uruguay)Original source

🌍Mar 13Industrycibeles.com.uyTier 1 · Company source

Grünöl

Cibeles (Uruguay)Original source

🌍Mar 13Industrycibeles.com.uyTier 1 · Company source

Cerio 75wg

Cibeles (Uruguay)Original source

🇺🇰Mar 12Industrycongenica.comTier 1 · Company source

SeqOne | Hébergement Données Santé

CongenicaOriginal source

🇺🇰Mar 12Industrycongenica.comTier 1 · Company source

Cookie policy

CongenicaOriginal source

🇨🇭Mar 12CDMObachem.comTier 2 · Direct publisher

Bachem reports strong sales growth and sustained high profitability

Bachem PeptidesOriginal source

🌍Mar 12Researchunityhealth.toTier 2 · Direct publisher

Meet Dr. Dalia Rotstein, the St. Michael’s neurologist dedicated to improving care for women during pregnancy

St. Michael's Hospital (Toronto)Original source

🌍Mar 12Mediaproscia.comTier 2 · Direct publisher

What Proscia’s Top KLAS Ratings Mean for Life Sciences Companies

ProsciaOriginal source

🇺🇰Mar 12Researchuclh.nhs.ukTier 2 · Direct publisher

NHS Staff Survey 2025 – we're the top recommended place to work for fourth year running!

University College London Hospitals (UCLH)Original source

🌍Mar 12Industryrelmada.comTier 1 · Company source

Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026

Relmada TherapeuticsOriginal source

🌍Mar 12Regulatorytransceleratebiopharmainc.comTier 1 · Regulatory source

From Vision to Value: A Blueprint for Implementing Industry Consortia Innovations

TransCelerate BioPharmaOriginal source

🇺🇸Mar 12Industrysolidbio.comTier 1 · Company source

Letter to the Duchenne Community

Solid BiosciencesOriginal source

🇯🇵Mar 12CROen.cmicgroup.comTier 2 · Direct publisher

CMIC Earns SBT Certification for Its Greenhouse Gas Reduction Targets — Driving Forward Its Decarbonization Commitment

CMIC Group JapanOriginal source

🇺🇰Mar 12Researchuclh.nhs.ukTier 2 · Direct publisher

UCLH and UCL researchers trial proton beam therapy in bid to transform treatment for mesothelioma

University College London Hospitals (UCLH)Original source

🇩🇪Mar 11Researchcharite.deTier 2 · Direct publisher

Active ingredient of Viagra helps treat rare genetic disease

Charité - Universitätsmedizin Berlin (EN)Original source

🇺🇸Mar 11Devicespathai.comTier 1 · Company source

PathAI Expands AISight® Dx with the v2.19 Release: Enhancing Flexibility, Collaboration, Reporting and Workflow Precision

PathAIOriginal source

🌍Mar 11Industrysubtlemedical.comTier 1 · Company source

Subtle Medical to Showcase AI Innovations at NVIDIA GTC 2026

Subtle MedicalOriginal source

🌍Mar 11Industryskyebioscience.comTier 1 · Company source

2025 Year-end & Q4 Financial Results and Update

Skye BioscienceOriginal source

🇯🇵Mar 10CROen.cmicgroup.comTier 2 · Direct publisher

CMIC Partners with Bluenote to Transform Clinical Development Operations with Agentic AI

CMIC Group JapanOriginal source

🌍Mar 10Industrybenitec.comTier 1 · Company source

Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for Oculopharyngeal Muscular Dystrophy (OPMD)

Benitec BiopharmaOriginal source

🌍Mar 10Industryuk-cpi.comTier 1 · Company source

From chemistry to component: New NCC and CPI partnership to strengthen UK materials capability

CPI (Healthcare Innovation)Original source

🇯🇵Mar 10Deviceshoya.comTier 1 · Company source

健康経営優良法人に10年連続で認定

HOYA MedicalOriginal source

🌍Mar 9Industrybenitec.comTier 1 · Company source

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference

Benitec BiopharmaOriginal source

🇺🇸Mar 7Industrybrukercellularanalysis.comTier 3 · Secondary coverage

AI Functional Antibodies: From Design to Cell Binding Candidates

Berkeley LightsOriginal source

🇩🇰Mar 6Regulatorylaegemiddelstyrelsen.dkTier 1 · Regulatory source

For Clinical Trials with ATMP: Guidance to the content of the Investigator´s Brochure published

Danish Medicines AgencyOriginal source

🇺🇸Mar 6Industryneogenomics.comTier 1 · Company source

Client support & resources

NeoGenomicsOriginal source

🇺🇸Mar 6Industrydyne-tx.comTier 1 · Company source

Dyne Therapeutics - A biotechnology company developing nucleic acid therapies for rare diseases.

Dyne TherapeuticsOriginal source

🌍Mar 6Industrycormedix.comTier 1 · Company source

CORMEDIX INC. REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

CorMedixOriginal source

🇫🇷Mar 6Researchpresse.inserm.frTier 2 · Direct publisher

Alzheimer’s: discovery of the involvement of new cells in the onset and progression of the disease

INSERMOriginal source

🌍Mar 5Industryorthofix.comTier 1 · Company source

How Surgeons Achieve Comprehensive Spinal Fusion with Facet Fixation

OrthofixOriginal source

🌍Mar 5Mediaseqens.comTier 2 · Direct publisher

Sale of our Limoges Botanical Actives and In Vitro Diagnostics activities to Solabia

SeqensOriginal source

🇺🇰Mar 5Researchuclh.nhs.ukTier 2 · Direct publisher

Award-winning author joins children to celebrate World Book Day

University College London Hospitals (UCLH)Original source

🌍Mar 5Industryuk-cpi.comTier 1 · Company source

UK hydrogen technology accelerator drives commercial momentum for clean tech startups

CPI (Healthcare Innovation)Original source

🌍Mar 5Mediaoxipit.aiTier 2 · Direct publisher

Oxipit enters agreement to be acquired by Sectra to scale autonomous AI in radiology

Oxipit (ChestLink for Thoracic X-ray/CT)Original source

🌍Mar 5Industrycuris.comTier 1 · Company source

Mt Sinai Comprehensive Cancer Center

CurisOriginal source

🇯🇵Mar 5Devicessysmex.co.jpTier 1 · Company source

Sysmex Announces New Group Mid-Term Management Plan

Sysmex (Global)Original source

🌍Mar 5Industryrss.globenewswire.comTier 3 · Secondary coverage

GH Research Reports Full Year 2025 Financial Results and Provides Business Update

GH ResearchOriginal source

🇺🇰Mar 5Researchstemcells.cam.ac.ukTier 2 · Direct publisher

Alcolea Group discovery on tumour development could help catch and treat cancer at earliest stages

Cambridge Stem Cell InstituteOriginal source

🇺🇰Mar 4Researchuclh.nhs.ukTier 2 · Direct publisher

UCLH accelerating research delivery

University College London Hospitals (UCLH)Original source

🌍Mar 4Industryorthofix.comTier 1 · Company source

Fitbone™ Trochanteric Lengthening System Launches Commercially in the U.S.: Expanding Precision Options for Internal Limb Reconstruction

OrthofixOriginal source

🇺🇰Mar 4Researchphar.cam.ac.ukTier 2 · Direct publisher

Department of Pharmacology Recent Publications: November 2025 - January 2026

Cambridge Pharma ResearchOriginal source

🇨🇭Mar 4Industryatinary.comTier 1 · Company source

Atinary Opens Self-Driving Labs® in Boston, Bringing AI into the Physical World of R&D

Atinary TechnologiesOriginal source

🇩🇪Mar 4Researchcharite.deTier 2 · Direct publisher

Mastering the jungle of guidelines with AI

Charité - Universitätsmedizin Berlin (EN)Original source

🇯🇵Mar 4CROen.cmicgroup.comTier 2 · Direct publisher

65th SOT Annual Meeting and ToxExpo

CMIC Group JapanOriginal source

🇯🇵Mar 4Devicessysmex.co.jpTier 1 · Company source

Sysmex Receives âHuman Capital Management Excellence 2025 Gold Awardâ for Outstanding Human Capital Management and Information Disclosure

Sysmex (Global)Original source

🇮🇱Mar 4Industryir.tevapharm.comTier 1 · Company source

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

Teva Pharmaceuticals RSSOriginal source

🌍Mar 4Medialemsurgical.comTier 2 · Direct publisher

Next Generation Surgical Humanoids: From Trajectory Guide to Therapeutic Executor

LEM Surgical (Dynamis Spine Robot)Original source

🌍Mar 4Industryproqr.comTier 1 · Company source

Meet Seda - Senior Director, Research Strategy and Innovation

ProQROriginal source